Arsenic early in treatment improves survival for leukemia patients, study finds

Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia, when administered after standard initial treatment, according to a new, multi-center study.

Read the whole article on Science Daily

More from Science Daily